Department of Neurosurgery, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands.
Department of Neurosurgery, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands.
Spine J. 2014 Feb 1;14(2):225-33. doi: 10.1016/j.spinee.2013.08.058. Epub 2013 Nov 13.
Patients with sciatica frequently experience disabling back pain. One of the proposed causes for back pain is vertebral end-plate signal changes (VESC) as visualized by magnetic resonance imaging (MRI).
To report on VESC findings, changes of VESC findings over time, and the correlation between VESC and disabling back pain in patients with sciatica.
STUDY DESIGN/SETTING: A randomized clinical trial with 1 year of follow-up.
Patients with 6 to 12 weeks of sciatica who participated in a multicenter, randomized clinical trial comparing an early surgery strategy with prolonged conservative care with surgery if needed.
Patients were assessed by means of the 100-mm visual analog scale (VAS) for back pain (with 0 representing no pain and 100 the worst pain ever experienced) at baseline and 1 year. Disabling back pain was defined as a VAS score of at least 40 mm.
Patients underwent MRI both at baseline and after 1 year follow-up. Presence and change of VESC was correlated with disabling back pain using chi-square tests and logistic regression analysis.
At baseline, 39% of patients had disabling back pain. Of the patients with VESC at baseline, 40% had disabling back pain compared with 38% of the patients with no VESC (p=.67). The prevalence of type 1 VESC increased from 1% at baseline to 35% 1 year later in the surgical group compared with an increase from 3% to 11% in the conservative group. The prevalence of type 2 VESC decreased from 40% to 29% in the surgical group while remaining almost stable in the conservative group at 41%. The prevalence of disabling back pain at 1 year was 12% in patients with no VESC at 1 year, 16% in patients with type 1 VESC, 11% in patients with type 2 VESC, and 3% in patients with both types 1 and 2 VESC (p=.36). Undergoing surgery was associated with increase in the extent of VESC (odds ratio [OR], 8.6; 95% confidence interval [CI], 4.7-15.7; p<.001). Patients who showed an increase in the extent of VESC after 1 year did not significantly report more disabling back pain compared with patients who did not show any increase (OR, 1.2; 95% CI, 0.6-2.6; p=.61).
In this study, undergoing surgery for sciatica was highly associated with the development of VESC after 1 year. However, in contrast with the intuitive feeling of spine specialists, those with and those without VESC reported disabling back pain in nearly the same proportion. Therefore, VESC does not seem to be responsible for disabling back pain in patients with sciatica.
坐骨神经痛患者常伴有严重的腰痛。磁共振成像(MRI)显示,椎体终板信号改变(VESC)是腰痛的一个可能原因。
报告 VESC 发现、VESC 随时间的变化以及 VESC 与坐骨神经痛患者腰痛之间的相关性。
研究设计/地点:一项为期 1 年的随访的随机临床试验。
6 至 12 周坐骨神经痛患者,参加了一项多中心、随机临床试验,比较早期手术策略与延长保守治疗与必要时手术的效果。
患者采用 100 毫米视觉模拟量表(VAS)评估腰痛(0 代表无痛,100 代表经历过的最严重疼痛),在基线和 1 年后进行评估。严重腰痛定义为 VAS 评分至少为 40 毫米。
患者在基线和 1 年随访时均接受 MRI 检查。采用卡方检验和逻辑回归分析,将 VESC 的存在和变化与严重腰痛相关联。
基线时,39%的患者有严重腰痛。基线时 VESC 阳性的患者中,40%有严重腰痛,而 VESC 阴性的患者中,38%有严重腰痛(p=.67)。与保守组从 3%增加到 11%相比,手术组的 VESC 类型 1 的发生率从基线时的 1%增加到 1 年后的 35%。手术组 VESC 类型 2 的发生率从基线时的 40%下降到 1 年后的 29%,而保守组的发生率则保持在 41%左右基本稳定。无 VESC 的患者在 1 年后出现严重腰痛的比例为 12%,VESC 类型 1 的患者为 16%,VESC 类型 2 的患者为 11%,VESC 类型 1 和 2 均有的患者为 3%(p=.36)。手术与 VESC 范围的增加有关(比值比[OR],8.6;95%置信区间[CI],4.7-15.7;p<.001)。与没有 VESC 增加的患者相比,VESC 增加的患者在 1 年后报告的严重腰痛并没有显著增加(OR,1.2;95%CI,0.6-2.6;p=.61)。
在这项研究中,手术治疗坐骨神经痛与 1 年后 VESC 的发展高度相关。然而,与脊柱专家的直观感觉相反,有和没有 VESC 的患者报告严重腰痛的比例几乎相同。因此,VESC 似乎与坐骨神经痛患者的严重腰痛无关。